Navigation Links
Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
Date:5/23/2008

CORONA, Calif., May 23 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the UBS Global Specialty and Generic Pharmaceuticals Conference on Wednesday, May 28, 2008 at 2:30 p.m. London BST (9:30 a.m. EDT).

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at http://ir.watson.com. The webcast can also be accessed at the following URL: http://events.webeventservices.com/ubs/2008/05/28/index.asp.

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc, headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Watson to Present at the Bank of America 2008 Healthcare Conference
2. Texas Senator Kirk Watson Honored as Champion for Children by the AMERIGROUP Foundation
3. Watson Files Application for Generic SEASONIQUE(R)
4. 60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG
5. Few Employers Addressing Workplace Stress, Watson Wyatt Surveys Find
6. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
7. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
8. Watson to Distribute Alendronate Tablets
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
11. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... 22, 2017 , ... Last year, 43 million gallons of surplus milk was ... While excess dairy can be caused by several factors, one pharmaceutical company CEO ... to properly digest lactose, a sugar found in milk and milk products. ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Vanderbeck Agency, a ... greater Nassau County region, is embarking on a combined charity effort with the Great ... For the last 25 years, the Great Neck Breast Cancer Coalition has worked to ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... financial planning assistance, and related services to families and business owners in the ... cooperation with the Leukemia & Lymphoma Society. , Every 3 minutes, someone in ...
(Date:3/22/2017)... ... ... The Senior Citizens League (TSCL) is calling on Congressional leadership to ... — including the debt held by the Social Security Trust Fund. “Congressional inaction ... to House and Senate budget leaders. “In prior debates to lift the debt ...
(Date:3/22/2017)... Hills, CA (PRWEB) , ... March 22, 2017 , ... ... 75 should not undergo PSA (prostate-specific antigen) screening, the cancer screening continues to stir ... in 2008 because it found that the risks outweighed the benefits. Now, news ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... RADNOR, Pennsylvania , 22 de marzo de ... proveedor independiente global líder de soluciones de productos ... ha anunciado hoy que ha adquirido EPL Archives, ... apoya a los clientes en todo el ciclo ... y comercialización ofreciendo una muestra de archivo, almacenamiento ...
(Date:3/22/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Respiratory care ... 10.9% over the next decade to reach approximately $38.27 billion by ... and forecasts for all the given segments on global as well ...
(Date:3/22/2017)...  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... data solutions, today reported financial and operational results ... December 31, 2016. 2016 Highlights ... 241% compared to the full year 2015  ... entire year  Direct-to-consumer model launched ...
Breaking Medicine Technology: